- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Changes in cAMP and cGMP levels induced by relaxing drugs in acetylcholine- and potassium-treated molluscan smooth muscle
Search this article
Description
Abstract 1. 1. The changes of cAMP and cGMP levels in response to serotonin, dopamine, papaverine and Aspaminol were investigated in acetylcholine- and potassium-treated molluscan smooth muscle in accordance with the time course of contraction-relaxation process in mechanical response to acetylcholine and potassium. 2. 2. Acetylcholine (10−5 M) and potassium (229 mM) had no influences on basal cAMP and cGMP levels. 3. 3. Serotonin (10−6 M and 10−5 M) dose-dependently elevated cAMP level and serotonin (10−5 M) reduced cGMP level in acetylcholine-treated muscle. 4. 4. Serotonin (10−5 M) elevated cAMP level and reduced cGMP level in potassium-treated muscle. 5. 5. Dopamine (10−6M and 10−5M), papaverine (10−4M) and Aspaminol (10−4M) had no effect on cAMP and cGMP level in acetylcholine- and potassium-treated muscle. 6. 6. Relaxing effect of serotonin may be associated with elevated cAMP level and reduced cGMP level at the pharmacological but not physiological level.
Journal
-
- Comparative Biochemistry and Physiology Part C: Comparative Pharmacology
-
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 70 171-176, 1981-01-01
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1874242817251229312
-
- ISSN
- 03064492
-
- Data Source
-
- OpenAIRE